ERα Mediates Estrogen-Induced Expression of the Breast Cancer Metastasis Suppressor Gene BRMS1

Area of Science:

• Endocrinology
• Cancer Biology
• Molecular Oncology

Background:

• Estrogen's role in cancer is complex, with evidence suggesting both tumor promotion and inhibition of metastasis.
• Estrogen's effects are mediated by specific estrogen receptor (ER) isoforms, influencing diverse cellular processes.

Purpose of the Study:

• To investigate how estrogen and its receptor regulate the expression of breast cancer metastasis suppressor 1 (BRMS1).
• To clarify the specific role of estrogen receptor alpha (ERα) in controlling BRMS1 expression in breast cancer cells.

Main Methods:

• Utilized multiple breast cancer cell lines (MCF-7, SKBR3, TTU-1, MDA-MB-231).
• Examined the effect of estrogen and ER subtype-specific agonists on BRMS1 transcription and expression.
• Employed small interfering RNA (siRNA) to knock down ERα expression.
• Confirmed protein level changes using Western blot analysis.

Main Results:

• Estrogen significantly increased BRMS1 transcription and expression in ERα-positive MCF-7 cells.
• The ERα-specific agonist PPT mimicked estrogen's effect, inducing BRMS1 expression.
• ERα knockdown using siRNA abrogated estrogen- and PPT-induced BRMS1 expression.
• Other ER subtype agonists did not affect BRMS1 expression.

Conclusions:

• Estrogen positively regulates BRMS1 expression specifically through the estrogen receptor alpha (ERα).
• This ERα-mediated upregulation of BRMS1 offers a novel mechanism for estrogen's potential metastasis-suppressive function.
• Findings provide new insights into the dual role of estrogen in breast cancer, particularly concerning metastasis.